OncologyEGFR tyrosine kinase inhibitorMade to order
Erlotinib hydrochloride
Also known as Tarceva
An EGFR tyrosine kinase inhibitor for non-small cell lung cancer and pancreatic cancer. Available on campaign basis for validated commercial programmes.
Full specification
Identity, quality, and supply.
- INN
- Erlotinib hydrochloride
- CAS number
- 183319-69-9
- Molecular formula
- C22H24ClN3O4
- Molecular weight
- 429.9 g/mol
- Therapeutic area
- Oncology
- Therapeutic class
- EGFR tyrosine kinase inhibitor
- Supplied as
- API
- Available scale
- Pilot (up to 25 kg)
- Stock status
- Made to order
- Storage
- As per COA
- Packaging
- HDPE drums, 5 kg net weight
- Brand names
- Tarceva
Highlights
What buyers care about.
- Cytotoxic-suite manufacturing
- Form B polymorph control
Related molecules
Full catalogue